Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Beginning Cash Balance (2017 - 2018)

Niagen Bioscience (NAGE) has disclosed Beginning Cash Balance for 7 consecutive years, with $45.4 million as the latest value for Q1 2018.

  • Quarterly Beginning Cash Balance rose 2664.25% to $45.4 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $47.0 million through Mar 2018, up 553.97% year-over-year, with the annual reading at $520000.0 for FY2013, 23.76% up from the prior year.
  • Beginning Cash Balance for Q1 2018 was $45.4 million at Niagen Bioscience, up from $429.0 in the prior quarter.
  • The five-year high for Beginning Cash Balance was $45.4 million in Q1 2018, with the low at $429.0 in Q3 2017.
  • Average Beginning Cash Balance over 5 years is $9.8 million, with a median of $3.1 million recorded in 2014.
  • The sharpest move saw Beginning Cash Balance plummeted 70.41% in 2017, then surged 2664.25% in 2018.
  • Over 5 years, Beginning Cash Balance stood at $2.3 million in 2014, then skyrocketed by 75.33% to $4.0 million in 2015, then skyrocketed by 39.98% to $5.5 million in 2016, then tumbled by 99.99% to $429.0 in 2017, then skyrocketed by 10580086.48% to $45.4 million in 2018.
  • According to Business Quant data, Beginning Cash Balance over the past three periods came in at $45.4 million, $429.0, and $1.6 million for Q1 2018, Q3 2017, and Q2 2017 respectively.